Jim Wright - Chief Scientific Officer @ BIND Therapeutics - Crunchbase Person Profile

Start Free Trial

Overview

CB Rank (Person)

Primary Job Title Chief Scientific Officer
Primary Organization
BIND Therapeutics

Location Lexington, Massachusetts, United States
Regions Greater Boston Area, East Coast, New England
Gender Male

LinkedIn View on LinkedIn

Jim Wright is the CSO at BIND Therapeutics.

Jobs

Number of Current Jobs

Number of Past Jobs

has

current jobs as

SVP of Drug Development

at

and

Chief Scientific Officer

at

BIND Therapeutics

. Additionally,

has had

past jobs including

CSO

at

BIND Therapeutics

.

Vivtex SVP of Drug DevelopmentNov 2018
BIND Therapeutics Chief Scientific Officer

Organization Name	Title At Company	Start Date	End Date
BIND Therapeutics	CSO	2007	2010
BIND Therapeutics	CSO	2008	2010
Millennium Pharmaceuticals	Vice President of Pharmaceutical Development	—	—
Infinity Pharmaceuticals	Vice President of Development	—	—
University of Wisconsin-Madison	Adjunct Professor	—	—
Alkermes	Senior Vice President of Development	—	—
Boehringer Ingelheim	Distinguished Scientist	—	—

Related Hubs

Hub Name	CB Rank (Hub)
New England Acquired Companies With Fewer Than 1000 Employees	4,141
Companies That Exited in 2013	5,502
New England Acquired Companies With Less Than $1B in Revenue	8,088
Greater Boston Area Companies With More Than 50 Employees	7,114
New England Acquired Companies With Less Than $500M in Revenue	8,372
Northeastern US Acquired Companies With Less Than $50M in Revenue	3,331
Northeastern US Medical Companies (Top 10K)	5,549
New England Acquired Companies With Less Than $50M in Revenue	9,891
Greater Boston Area Acquired Companies With Fewer Than 100 Employees	15,727
Massachusetts Health Care Companies	13,205

Education

studied at

University of California, Santa Barbara

and

University of Wisconsin-Madison

.

University of California, Santa Barbara BABiology and Chemistry
University of Wisconsin-Madison Ph.DPharmacy

Recent News and Activity

Number of News Articles

News•

Jul 1, 2020

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Jun 30, 2020

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Feb 28, 2020

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Feb 20, 2020

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Aug 21, 2017

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated